NOW

AlphaSorb-C 1000

F
N+ Score46
Joint & BoneServing: 1 Tablet(s)Type: Other Combinations

AlphaSorb-C 1000 from NOW is an "Other Combinations" supplement, categorized under Joint & Bone, primarily focused on Vitamin C delivery. Each tablet contains 1 gram of Vitamin C, 120 mg of Calcium, 1.3 grams of Transport C-PLUS®, and a blend of bioflavonoids including 75 mg of Citrus Bioflavonoid Complex. This product has 7 ingredients and received an N+ Score of 46, earning it an F grade, indicating a below-average quality assessment. Research suggests that both Vitamin C and Calcium are present in underdosed amounts for certain clinical applications, despite the 1-gram Vitamin C dose being common. It may be suitable for those seeking a general Vitamin C supplement with added bioflavonoids.

About This Product

AlphaSorb-C 1000 by NOW is a joint & bone supplement containing 7 active ingredients. It has earned an N+ Score of 46/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Several ingredients below clinically effective doses
  • −Missing several expected ingredients for its category

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Vitamin C1.000 gUnder
Calcium120.000 mgUnder
Citrus Bioflavonoid Complex75.000 mgN/A
Rose Hips powder25.000 mgN/A
Acerola powder25.000 mgN/A
Rutin powder25.000 mgN/A
Transport C-PLUS(R)1.300 gN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.